This combination of antiHIV agents generally result in higher viral suppression, higher CD4 cell count recovery rates, a higher genetic barrier to developing drug resistance, a lower risk of treatment discontinuation and clinical activity against HIV-2 infection relative to treatment with tenofovir and 3TC (or FTC) plus efavirenz.

Question

Quizplus · Accepted Answer

Tenofovir and 3TC (or FTC) plus dolutegravir is known for its high efficacy in suppressing HIV viral load, improving CD4 cell counts, offering a high barrier to resistance, having fewer reasons for treatment discontinuation, and being effective against HIV-2, compared to the regimen with efavirenz.

This Combination of AntiHIV Agents Generally Result in Higher Viral